; and (C) the long-term promotion of trans­la­tion­al research for vision impairment and other diseases, disabilities, and syndromes congenital to vision impairment or caused by vision impairment, taking into account features that are valuable after any authorization for expanded use of a limited Federal guarantee for biomedical translational research for other diseases and disabilities. (b) Compensation for issuers The issuer of an eye bond shall be compensated from the proceeds from the sale of such eye bond at such rate and on such terms as the Secretary may provide. (c) Public disclosures with respect to eye bonds (1) In general Not less than 2 business days before the date on which an issuer issues an eye bond, the issuer shall file with the Securities and Exchange Commission, and make available to the public, the following information: (A) The nature of all projects funded by the eye bond. (B) The name of any principal individual or institution that will be conducting each project. (C) The milestones established for each project. (D) A determination by the issuer as to whether each project funded by the eye bond has appropriately protected intellectual property. (E) The structure of the eye bond. (F) The interest payment schedule for the eye bond. (G) The anticipated returns and risks of the eye bond. (H) Such other information as the Commission determines necessary or appropriate in the public interest or for the protection of investors. (2) Rulemaking (A) In general Not later than 180 days after the date of enactment of this Act, the Securities and Exchange Commission shall issue regulations to carry out this subsection. (B) Authority of the Secretary If the Securities and Exchange Commission does not issue the regulations required under subparagraph (A) before the end of the 180-day period described under subparagraph (A), the Secretary shall issue regulations to carry out this subsection before the end of the 60-day period beginning on the end of the 180-day period described under subparagraph (A). 6.